Sculptor Capital LP - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 152 filers reported holding WUXI PHARMATECH CAYMAN INC in Q3 2015. The put-call ratio across all filers is 2.14 and the average weighting 0.7%.

Quarter-by-quarter ownership
Sculptor Capital LP ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$74,047,000
+98.3%
1,713,645
+94.0%
0.26%
+138.9%
Q2 2015$37,332,000883,3900.11%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q3 2015
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 241,186$9,353,00020.89%
Sensato Investors LLC 672,513$26,080,0005.62%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 2,781,889$107,882,0003.77%
Sloane Robinson LLP 57,500$2,230,0003.35%
Grandeur Peak Global Advisors, LLC 344,518$13,360,0002.83%
THOMAS WHITE INTERNATIONAL LTD 474,694$18,409,0002.58%
Granite Point Capital Management, L.P. 180,000$6,980,0002.56%
COMGEST GLOBAL INVESTORS S.A.S. 2,058,180$79,816,0002.49%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 234,071$9,077,0002.47%
DECADE CAPITAL MANAGEMENT LLC 389,735$15,114,0001.87%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders